The new hepatitis C era: the guidelines are now available, reimbursement not yet.

Neth J Med. 2014 Oct;72(8):386-7.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antiviral Agents / economics*
  • Cost-Benefit Analysis
  • Hepatitis C / drug therapy*
  • Hepatitis C / economics*
  • Humans
  • Insurance, Health, Reimbursement / economics
  • Netherlands
  • Practice Guidelines as Topic
  • Quality-Adjusted Life Years

Substances

  • Antiviral Agents